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Abstract 
Eukaryotic RNA binding proteins (RBP) are key players in RNA processing and in post-transcriptional regulation of gene expression. By 
interacting with RNA and other factors and by modulating the RNA structure, they promote the assembly of a great variety of specific ribonu- 
cleoprotein complexes. Many RBPs are composed of highly structured and conserved RNA binding domains (RBD) linked to unstructured and 
divergent auxiliary domains; such modular structure can account for a multiplicity of interactions. In this context, the auxiliary domains emerge as 
essential partners of the RBDs in both RNA binding and functional specialisation. Moreover, the determinants of biologically important functions, 
such as strand annealing, protein-protein interactions, nuclear localization and activity in in vitro splicing, seem to reside in the auxiliary domains. 
The structural and functional properties of these domains suggest heir possible derivation from ancestral non-specific RNA binding polypeptides. 
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1. Introduction 
A great deal of gene expression regulation in mammal- 
ian cells acts on the flow of post-transcriptional events 
that starts with the release of newly synthesised pre- 
mRNA from the active chromatin in the form of a ribo- 
nucleoprotein fibre, continues with processing in the nu- 
cleus, transport of mature mRNA in the cytoplasm and 
ends with translation into proteins. During each of these 
steps the RNA is bound to a plethora of proteins. Con- 
trary to DNA, which is a relatively passive substrate of 
truns-acting factors, RNA participates as an active pro- 
tagonist in its own fate. In fact each step of the pre- 
mRNA processing (capping, splicing, 3’ end formation 
etc.) entails the formation of specific RNA-protein as- 
semblies involving both truns-acting interactions with 
proteins and ribonucleoprotein particles and c&acting 
interactions within the RNA itself. The sequence diver- 
sity and structural versatility of RNA can account for an 
enormous number of specific interactions. Thus, the for- 
mation of specific RNA-protein complexes should be 
viewed as a dynamic process whereby RNA sequence 
and conformation direct the binding of trans-active fac- 
tors which, upon binding, can in turn modulate the RNA 
structure towards an appropriate conformation. Along 
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this line, it is tempting to consider certain ribonucleopro- 
tein complexes as the modern version of the catalytic 
RNAs that might have populated a primordial ‘RNA 
world’ and some of the proteins that nowadays associate 
with the RNAs as ‘enhancers’ of the RNA potentialities 
[l]. This type of ‘scenario’ has in fact been invoked for 
the spliceosome [2,3] and for the ribosome [4]. 
In this perspective the identification and molecular 
characterisation of the RNA binding proteins (RBPs) is 
of outmost interest even if the number and diversity of 
such proteins constitutes a formidable experimental 
challenge. An initial rationalisation of the whole field 
was achieved through the identification of specific nu- 
clear RNA-protein assemblies (such as the hnRNP parti- 
cles, the snRNP and more recently the spliceosome com- 
plex) and the molecular characterisation of their protein 
constituents. The results of these studies revealed that 
many RBPs can be grouped into families and sub-fami- 
lies on the basis of common structural and functional 
domains [5-71. Such domains, which are often conserved 
in evolution, have in turn been used as diagnostic motifs 
to identify other proteins and to expand the respective 
families [8]. One such motif was first identified through 
the comparison of the primary sequences of two nuclear 
proteins: the poly(A)-binding protein (PABP) and the 
hnRNP protein Al [9] and was then found in other pro- 
teins involved in different steps of the RNA processing. 
This motif termed RBD from RNA binding domain (but 
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Fig. I. Alignment of selected RBD sequences from four human RBPs. The common tertiary folding and the RNP 1 and RNP 2 consensus are outlined. 
For a more complete compilation and further details see [6]. 
also RNA recognition motif (or RRM [lo]) or RNP 80 
[l l] motif by some authors) consists of 80-90 conserved 
amino acids containing two stretches of 8 and 6 highly 
conserved residues called RNP 1 and RNP 2 respectively 
[12] (see Fig. 1). Several lines of evidence point to the 
RBD domain as being one of the diagnostic determi- 
nants of RNA binding 181. The finding that specific resi- 
dues in the RNP sequences make direct contacts with 
nucleic acid 1131 brings further support to this conten- 
tion, even if the involvement of flanking sequences eems 
likely, at least in some cases [6,11]. The tertiary structure 
of two RBDs, one from protein Ul A of Ul snRNP and 
one from the hnRNP protein Cl, was dete~ined by 
X-ray crystallography and NMR, respectively [14,15]. In 
both cases the structure consists of 4 anti-parallel B- 
strands forming a B-sheet connected by 2 ol-helices on 
one side. On the basis of these and other data a model 
was devised by which the P-sheet constitutes a binding 
surface where the bound RNA is exposed to the solvent 
in a configuration available for other interactions. It is 
now generally accepted that the RBD is an important 
determinant of RNA binding present in a great number 
of proteins and its importance is strengthened by the 
observation that, at least in some cases, it contains also 
the determinant for sequence/st~cture specificity. Thus 
the RBD could be envisaged as the ‘RNA world’ coun- 
terpart of DNA binding motifs such as, for example, the 
helix-loop-helix or Zn-finger structures of transcription 
factors. It is interesting to note that the analogy between 
some DNA and RNA binding proteins extends further 
to overall structural organisation which in both cases is 
a modular assembly of different domains [16,17]. More- 
over, much in the same way as transcription factors con- 
tain different activating domains linked to similar DNA 
binding motifs, the RBPs of the RBD family are also 
characterised by a variety of auxiliary domains. Al- 
though the function of these domains is still largely un- 
known, increasing evidence points to them as important 
determinants in the formation of specific supramolecular 
complexes. 
2. Structure and specificity of the RBD proteins 
As mentioned above a distinctive feature of RBD pro- 
teins is a modular structure in which one or more RBD 
domains are associated with one or more auxiliary do- 
mains, Some proteins possess only one RBD and one 
auxiliary domain while others have multiple RBDs and 
auxiliary domains assembled in different ways [ 1611. 
While RBD domains are usually rather well conserved 
in sequence, the auxiliary domains are widely divergent. 
However, some proteins appear to have similar auxiliary 
domains and, on this basis, a classification can be pro- 
posed. A schematic representation of the structure of the 
most representative RBD polypeptides is shown in 
Fig. 2. 
What is the role of the two types of domains? The 
molecular dissection of a few well-characterised RBPs 
and a number of in vitro studies performed with their 
recombinant counterparts have provided some answers 
but at the same time have raised new questions. In partic- 
ular, the schematic view that considers the RBD domain 
as the main RNA binding determinant, relegating the 
auxiliary domains to undefined interactions, should be 
reconsidered (see below) and, moreover, a differentiation 
of functions between apparently similar RBDs has 
emerged. In fact, in the case of the yeast poly(A)-binding 
protein (PABP), containing 4 RBDs, initial in vivo stud- 
ies indicated that only one of the 4 RBDs is essential for 
viability and at the same time sufficient for stable RNA 
binding in vitro [I 81. However, the single RBDs are con- 
served in evoiution [ 121 suggesting a specific role for each 
of them. 
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Fig. 2. Schematic representation of the modular structure of some representative RBD-type RNA binding proteins. Boxes represent structural and/or 
functional proteins domains. Conserved RBD domains are indicated by roman numbering (I-IV). Auxiliary domains are designated on the basis 
of their distinctive features (see text). White boxes represent uncharacterized regions. For further details see references given in parentheses in the 
figure. 
On the other hand more recent in vitro studies with 
constructs consisting of different parts of the yeast PABP 
and with different pair-wise combinations of the 4 RBDs 
showed that none of the individual RBDs binds poly(A) 
specifically or efficiently while contiguous two-domains 
are required for efficient binding. Moreover, each pair- 
wise combination has distinct RNA binding activity and, 
while the two amino-terminal RBDs are dispensable for 
viability of yeast, the two carboxy-terminal ones are re- 
quired [19]. It appears, therefore, that the 4 RBDs of 
PABP constitute a multifunctional polypeptide with at 
least two separable activities: the two amino-terminal 
RBDs, most likely involved in specific binding to the 
poly(A) tail, and the other two RBDs, which are engaged 
in interactions either with a different part of the same 
mRNAs or with other factors. Most likely the main role 
of the RBDs domains is to confer some kind of binding 
specificity, as also indicated by the fact that most RBD 
containing proteins (e.g. PABP, hnRNP Al, Cl and 
snRNA binding proteins, etc.) show a clear preference 
for certain sequences [6,11,20,21]. Moreover, in the case 
of proteins containing multiple RBDs (PABP, U2AF65), 
each repetition confers different sequence specificity 
[19,22]. A rather convincing demonstration of sequence 
specificity was provided in the case of proteins UlA and 
U2B” of snRNP Ul and U2, respectively. It was shown, 
in fact, that the replacement of 8 amino acids in the RBD 
of UlA with the corresponding ones of the homologous 
protein U2B” confers to the former the sequence speci- 
ficity of the latter [23]. On the other hand, as will be 
shown below, the RBD does not account for the whole 
binding capacity of the protein since some auxiliary do- 
mains contribute significantly to the overall RNA bind- 
ing free energy, thus putting the overall functional organ- 
isation of RNA binding proteins into a new perspective. 
3. Types of auxiliary domains 
It is difficult to classify the auxiliary domains of the 
RBP proteins on the basis of their amino acid sequence 
and, moreover, the almost complete lack of functional 
data hampers the identification of distinctive structural 
elements. Interestingly, however, the analysis of certain 
RBP auxiliary domains reveals the presence of features 
commonly found in the activating domains of transcrip- 
tion factors. For example, hnRNP C has a very acidic 
auxiliary domain [24] while those of other proteins are 
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Fig. 3. Visualisation of the ‘RGG box’ consensus [52] in the auxiliary domains of hnRNP protein Al and nucleolin. The GAR domain of nucleolin 
is boxed. Recurrence of aromatic residues (F,Y) is indicated. Asterisks mark the position of basic residues (K,R). 
very rich in Q, P, A or M residues [9,18,25-301. By anal- 
ogy with transcription factors, it was suggested that these 
types of RBP domains could also be involved in protein- 
protein interactions. In this regard the auxiliary domain 
of the 64 kDa subunit of the human polyadenylation 
factor seems to fit this prediction since it contains a 
twelve-fold repetition of an MEARA/G consensus form- 
ing an extended a-helix which is likely to interact elec- 
trostatically with other proteins [3 11. Altogether, our un- 
derstanding of structure-function relationships in these 
domains is still scanty and complicated by the possibility 
that they might be involved in unpredictable functions. 
The case of protein UlA of snRNP Ul is emblematic of 
this situation. Its 100 amino acid long auxiliary domain 
was recently dissected by deletion mutagenesis and it was 
found that the entire region is required for the nuclear 
localisation of the protein [32]. In effect, this domain 
constitutes a completely new type of nuclear localisation 
signal. Moreover, the considerable size (110 amino acids) 
makes it unlikely that nuclear localisation is its only 
function. 
It is not easy, therefore, to rationalise these results. 
However, in spite of these difficulties, two broad groups 
of RBP auxiliary domains can be envisaged, character- 
ised by significant structural and functional similarities. 
The first group includes the so-called Gly-rich domains 
found in most basic hnRNP proteins, in nucleolin, in 
fibrillarin and in several yeast RBPs [5,33-361. These 
domains have an abnormally high C content and are also 
characterised by the presence of more-or-less regularly 
interspersed basic and aromatic residues [33,37]. 
Many of these proteins have been studied in detail 
and, along with remarkable similarities, significant dif- 
ferences have emerged. For example, in human nucleo- 
lin, in fibrillarin and in yeast NSRl protein, all involved 
in the processing of pre-rRNA, the Gly-rich region is 
organised into the so-called GAR domain [33] character- 
ised by a repetition of the RGGXGGR sequence (where 
X is generally F or less frequently S, Y, A) that can form 
a series of B-turns producing a B-spiral that is likely to 
interact with RNA [38,39]. In contrast, no such defined 
structure can be seen in the Gly-rich domains of the basic 
hnRNP proteins [33] which, however, as will be shown 
below, have significant RNA binding activity further 
evidencing the difficulty of relating function to structure. 
The second group comprises the so-called SR domains 
that are found in splicing factors of the SR family (SF2, 
SC35, etc.) [40], in U2AF [22], in splicing regulators of 
Drosophila (tra and tra-2) [41,42] and also in the 70 kDa 
protein of snRNP Ul [43]. It is now believed that the 
presence of an SR motif is diagnostic of activity in splic- 
ing [44]. In the SR protein family these domains consti- 
tute SR dipeptide runs the length of which is a distinctive 
feature of each member. On the other hand, in Droso- 
phila factors tra and tra-2, the SR dipeptides are embed- 
ded in a basic milieu (K, R) [41,42], while in Ul 70K 
protein, SR runs are mixed with RE and RD dipeptides 
and G hinges [45]. The SR region of the splicing factor 
U2AF is even more complex than the previous ones [22]. 
Thus, while the occurrence of SR domains in different 
proteins suggests a common biochemical function [44], 
their different sizes and spatial relationship with respect 
to neighbouring motifs, could determine the different 
functional roles. Such a possibility is further supported 
by the observation that the SR domains (as well as some 
Gly-rich domains) are subject to regulated alternative 
splicing and to post-translational modifications ([46648], 
see below). 
4. RNA binding properties of the RBPs auxiliary domains 
The role of the RBD domains in RNA binding is 
confirmed by numerous experimental data [ 10,11,49,50]. 
Moreover, as previously mentioned, the tertiary struc- 
ture of two such domains provides a plausible model for 
such interaction [14]. Surprisingly, however, the RBD 
domain is not the only portion of the protein that makes 
contacts with the RNA since, in many cases, the Gly-rich 
and the SR auxiliary domains were found to contribute 
significantly to the binding free energy of the entire pro- 
tein. It was shown, for example, that the Gly-rich domain 
of hnRNP protein Al contributes about half of the bind- 
ing free energy of the entire protein [51]. Also the GAR 
domains of nucleolin and fibrillarin were extensively 
characterised; as already mentioned they can adopt a 
p-spiral structure able to bind and unfold the RNA [38]. 
Accordingly, a synthetic polypeptide consisting of a 7- 
fold repetition of the GNFGGGRGGNYGGSRG con- 
sensus, matching both Al and nucleolin, binds RNA 
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Fig. 4. A tentative model of RBD domain and auxiliary domain contri- 
bution to RNA binding and sequence specificity. The protein binds 
aspecifically to RNA with the auxiliary domain, then migrates (arrow) 
to an high affinity site where a conformational change could take place 
(for further details see text). 
with high affinity and causes unfolding of bases [37]. 
Thus, in spite of substantial sequence divergence, the 
auxiliary domains of Al and nucleolin must actually 
encode similar binding determinants. Such determinants 
have not been fully elucidated; interestingly however, 
both proteins show similarities to the so-called ‘RGG 
box’, a motif demonstrated to be the key RNA binding 
element in the hnRNP protein U [52] (see Fig. 3). 
Concerning the SR domains, a direct demonstration 
of RNA binding was initially attained in the splicing 
factor, U2AF, where it was actually shown to contribute 
most of the RNA binding activity [53]. More recently, 
also the SR domain of SF2/ASF splicing factor was 
found to exhibit efficient RNA binding [44,45] while, 
surprisingly, the RBD domain of this protein binds RNA 
only inefficiently [54]. On the basis of several preliminary 
indications it seems likely that other SR domains will 
turn out to bind RNA. It should be noticed that both the 
Gly-rich and the SR auxiliary domains seem to bind 
RNA aspecifically. Thus, a general mechanism could be 
proposed by which the auxiliary domains play the impor- 
tant role of aspecifically ‘anchoring’ the protein to the 
RNA, allowing the cognate RBD domain to make more 
specific contacts (see Fig. 4). 
5. Involvement of auxiliary domains in protein-protein 
contacts 
As already mentioned, the auxiliary domains of RBPs 
have often been proposed to mediate protein-protein 
interactions, by analogy with the activating domains of 
transcription factors. In many cases such interactions are 
deduced simply on the basis of co-immunoprecipitation 
or co-localization experiments [55,56] while in others the 
evidence is more direct. For example, several results sug- 
gest that some SR-type splicing factors specifically inter- 
act with the splicing regulators tra and tra-2 of Droso- 
phila to form a splicing enhancer complex that controls 
alternative splicing of doublesex pre-mRNA [57]. An- 
other likely candidate is protein UlA, a constituent of 
Ul snRNP that interacts with a specific segment of the 
snRNA. Interestingly, when such a segment is deleted, 
UlA still binds to the particles, presumably via contacts 
with the protein moiety [ll]. A further example is the 
interaction between the two subunits (35 and 65 kDa) of 
the splicing factor, U2AF, where a detailed deletion 
analysis identified two protein domains with opposite 
charges, presumably mediating electrostatic interactions 
[581. 
Recent experiments trongly suggest a direct interac- 
tion between protein PTB (pyrimidine tract binding; 55 
kDa, identical to hnRNP I) and the splicing factor, PSF 
(which binds to the 3’ splice site and is required for the 
first step of spliceosome assembly [28]. In this case, the 
P/Q-rich domains of the two proteins are probably in- 
volved, as in the case of certain trandscription factors 
[59,60]. 
A role of the SR domain in protein-protein interac- 
tions is also deduced from experiments performed on the 
Drosophila splicing regulator, sxl (that lacks an SR do- 
main), fused to a heterologous SR domain. Unlike the 
wild-type protein, the hybrid protein can substitute the 
splicing factor, U2AF, in bringing the U2 snRNP to the 
branch site on the tra gene pre-mRNA [61]. This result 
is interpreted by assuming that the SR domain confers 
the novel capacity to bind a snRNP particle. 
The Gly-rich auxiliary domain of hnRNP protein Al 
provides the most convincing evidence of protein binding 
capacity. Such a property was initially suggested by the 
observation that its presence greatly enhances the coop- 
erativity of binding to the RNA compared to that of the 
protein lacking such a domain. (UPl) [62]. Moreover, a 
synthetic oligopeptide of 42 amino acids covering part of 
the Gly-rich domain was found to bind RNA coopera- 
tively [51]. We have recently investigated the interactions 
mediated by the auxiliary domain of Al with a more 
direct assay. For this, a hybrid protein consisting of the 
Gly-rich domain fused to GST and bound to glutathi- 
one-agarose beads was used to assay the retention of 
other proteins in affinity chromatography. We found 
that the entire Al protein is specifically retained even at 
high salt concentration (0.4 M NaCl) while the protein 
lacking the Gly-rich domain (UPl) is not. Thus, this 
domain is absolutely required for protein-protein con- 
tacts (in preparation). Initial deletion analysis indicated 
that protein binding determinants are distributed over 
the entire length of the domain and are probably identi- 
fiable in the periodic recurrence of aromatic residues, in 
accord with the hydrophobic nature of interaction. In the 
same type of experiments we observed that proteins such 
as the hnRNP basic proteins A2, Bl, B2 and hnRNP C, 
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are efficiently retained by the auxiliary domain of Al 
while other hnRNP proteins (e.g. hnRNP I) are not 
bound (in preparation). Obviously the notion that an 
auxiliary domain can establish specific contacts with it- 
self and with other RBPs in the absence of RNA has 
important implications in explaining the assembly of spe- 
cific multi-protein complexes on the pre-mRNA. More- 
over, because of their plasticity and multiplicity, protein- 
protein interactions could also play an unexpected role 
in other processes, as discussed in the next sections. 
6. Annealing activity 
In the last few years it has become increasingly evident 
that many RBPs can efficiently promote intra-strand 
RNA annealing in vitro. Interestingly, such activity 
seems to involve primarily the auxiliary domains. In nu- 
cleolin, for example, re-annealing depends on the pres- 
ence of the GAR domain which, incidentally, is also 
responsible for the helix-destabilizing activity of this pro- 
tein [38,39,63]. Similarly, in hnRNP protein Al, the Gly- 
rich domain is entirely responsible for reannealing. Actu- 
ally the isolated Gly-rich domain of Al (without any 
RBD) is able to efficiently promote reannealing [64-661. 
More recently other hnRNP proteins [67] and several SR 
proteins [53,68] have been shown to promote annealing. 
Protein Al, which is the best studied case, increases up 
to 500-fold the rate of renaturation [69]. Protein Al acts 
both by lowering the annealing temperature and by shift- 
ing the DYSS equilibrium toward the DS form. In fact, 
in the presence of Al there is no complete duplex denatu- 
ration even at very high temperatures [69]. All these ef- 
fects could be accounted for by the ability of the Gly-rich 
domain to establish protein-protein and protein-RNA 
interactions through basic and aromatic residues regu- 
larly interspersed in a flexible structure. In fact, the coop- 
erative binding of many such flexible structures to the 
RNA can both cause the shielding of phosphates and the 
stabilisation of relatively open RNA structures in which 
nucleotides are exposed and available for interaction. In 
support of this mechanism is the observation that certain 
long-chain cationic detergents can mimic the reannealing 
activity of the Gly-rich domain [70]. In the case of Al, 
protein-protein interactions mediated by the Gly-rich 
domain could further accelerate renaturation by bring- 
ing the covered complementary strands in close proxim- 
ity. Such interaction, however, although probably rele- 
vant, seems not strictly required. In fact, the isolated 
RBD domain of hnRNP protein Cl, presumably not 
involved in protein-protein interactions, has limited but 
significant reannealing activity, indicating that RNA 
binding proteins could reanneal RNA strands simply by 
acting as ‘chaperons’ of RNA conformation [67]. 
As already mentioned, several splicing factors contain- 
ing SR motifs exhibit strand-annealing activity [53,68] 
but only for the U2AF factor was such activity unequivo- 
cally attributed to the SR region [53]. 
What is the biological significance of the reannealing 
capacity of many RBPs? Although there is no evidence 
that such a reaction is actually relevant in vivo it is 
tempting to speculate that the hnRNPs and other RBPs, 
in addition to recruiting factors through protein-protein 
interactions, favour the correct folding of the RNA dur- 
ing processing by acting as chaperons and match makers. 
Indeed it is difficult to envisage the assembly of the spli- 
ceosome and the splicing of introns without invoking 
reactions of the kind described above. One significant 
example in this regard could be the ennealing of U4 and 
U6 snRNPs promoted by the yeast protein PRP24 [71]. 
Further support for the biological role of annealing 
activity derives from the observation that some RBPs 
(including hnRNP protein Al) can enhance hammer- 
head ribozyme catalysis in vitro [l]. Ribozymes act by 
recognising and annealing to an RNA target sequence 
the length of which usually determines a strong binding 
and a slow dissociation rate which limits the specificity 
for the substrate. Thus, it is conceivable that proteins 
able to accelerate RNA association and/or dissociation 
can enhance ribozyme activity and specificity. This fur- 
ther example of protein-RNA synergism brings new sup- 
port to the idea that non-specific RNA binding peptides 
were introduced into a ‘RNA world’ early in evolution, 
probably to enhance the RNA potentialities. From this 
point of view, the auxiliary domains of RBP could be the 
molecular remnants of such aspecific RNA binding pep- 
tides to which more organised domains (RBD) were sub- 
sequently joined. 
7. Nuclear localisation 
Many RBD-type RBPs contain canonical nuclear lo- 
calisation signals identified by homology with the SV40 
large T-antigen motif. In some RBPs, however, no such 
signals are recognisable while, interestingly, atypical lo- 
calisation determinants eem to be located in auxiliary 
domains. Several examples in this regard have already 
been reported. As previously mentioned, the entire auxil- 
iary domain of protein UlA is implicated in the nuclear 
import of this protein [32]. The SR domains of Droso- 
philu splicing regulators tra and SU(W’~ are responsible 
not only for nuclear localisation but also for the typical 
‘speckled’ intranuclear pattern, probably due to stable 
association with insoluble nuclear structures [72]. We 
have recently demonstrated by means of transfection ex- 
periments with appropriate constructs, that the Gly-rich 
domain of hnRNP protein Al contains all the determi- 
nants for the nuclear import of this protein. Interest- 
ingly, such determinants overlap those of RNA binding 
and protein-protein interactions (paper in preparation). 
Although no precise definition of the minimal sequences 
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required for nuclear localisation was attained in any of 
these proteins, the above reported findings further ex- 
pand the spectrum of activities of the auxiliary domains 
of RNA binding proteins and raise the possibility that 
a single RBP might be active in different steps and at 
different times during RNA processing. 
8. Auxiliary domain modifications 
The auxiliary domains of many RBPs undergo a num- 
ber of post-transcriptional and post-translational modi- 
fications that modulate their structural and functional 
properties. For example, the SR dipeptides in the SR 
auxiliary domains are often phosphorylated, as demon- 
strated for several splicing factors [73] and for the 70 kDa 
protein of the Ul snRNP [74]. The effect of such modifi- 
cation is not yet fully understood. However, it was 
shown that Ul snRNP containing a phosphorylated 70 
kDa protein is inactive in in vitro splicing reactions [74]. 
A protein kinase associated to the Ul snRNP and re- 
sponsible for 70 kDa protein phosphorylation was re- 
cently described [75]. It was proposed that the same ki- 
nase could phosphorylate other spliceosome proteins 
such as SR proteins and splicing regulators. Many of 
these factors, in fact, are phosphorylated in vivo, as indi- 
cated by their aberrant electrophoretic mobility. In the 
case of the splicing factor, SF2/ASF, the most 
phosphorylated region (residues 200-224) is the same as 
that which is necessary and sufficient to provide the SR 
function in constitutive splicing assay [44,75]. Also, 
many hnRNP proteins (e.g. A/B, C, U) are 
phosphorylated in vivo and in some instances (e.g. 
hnRNP A2 and C) in a cell cycle-dependent fashion 
[76,77]. A specific kinase that phosphorylates hnRNP 
protein C was described [77] and it was proposed that 
specific phosphorylation/dephosphorylation steps could 
control the binding and the release of hnRNP C from 
complexes assembled on the pre-mRNA [78]. Interest- 
ingly, several experiments indicate that phosphorylationl 
dephosphorylation cycles could direct the sequential 
binding of splicing factors and snRNPs to the pre- 
mRNA and influence specific catalytic steps of the splic- 
ing reaction [79]. 
Concerning hnRNP Al, we showed that the in vitro 
phosphorylation of Ser”’ in the Gly-rich domain by pro- 
tein kinase A (PKA) reduces the affinity of the protein 
for nucleic acid and abrogates strand annealing activity 
[80]. It should be pointed out, however, that the site of 
in vivo phosphorylation of this protein has not yet been 
determined. 
In addition to phosphorylation, another in vivo mod- 
ification, i.e. the dimethylation of one or more R resi- 
dues, is often observed in the Gly-rich domains of many 
basic hnRNP proteins and of nucleolin [34,81]. The ef- 
fect of this modification is not known; it is possible, 
however, that, in analogy to what is observed with the 
TAT protein of HIV, it might influence RNA binding 
WI. 
9. Conclusions 
Most eukaryotic RNA binding proteins appear to be 
an assembly of different structural modules. One such 
module, the RBD domain, is a conserved highly struc- 
tured RNA binding motif, widely shared among proteins 
involved in different steps of RNA processing. The RBD 
is responsible, at least in part, for the sequence-structure 
specificity of binding. Linked to the RBDs are highly 
variable modules, the so called auxiliary domains, that 
identify different groups of proteins. Contrary to the 
RBD, the auxiliary domains are largely unstructured and 
characterised by monotonous repetitions of distinctive 
amino acids. Quite surprisingly, however, the auxiliary 
domains appear to be key functional constituents of 
RNA binding proteins since they: (i) contribute to non- 
specific RNA binding and modulate RNA conforma- 
tion; (ii) mediate the interactions with other proteins; (iii) 
determine the intracellular localisation of the proteins. 
The binding specificity of RBDs and the plasticity of 
auxiliary domain interactions seem suitable to account 
for the assembly of specific ribonuclear complexes along 
the RNA. In the hypothesis of a transition from a pri- 
mordial ‘RNA world’ to the present situation it is tempt- 
ing to view the auxiliary domains as the descendants of 
the ancestral simple polypeptides that must have non- 
specifically bound the RNA to enhance its potentiality; 
the present form of RBP could therefore be the result of 
the addition later in evolution of more specific binding 
determinants uch as the RBDs. 
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